Abstract: Provided herein, inter alia, are compounds, pharmaceutical compositions and methods related to the treatment of viral infections caused by coronavirus or enterovirus. Provided herein are compounds of Formula (I), (II) and (III) and methods of using the compounds for therapy. These compounds are peptidomimetics that inhibit protease 3CL of a coronavirus, and are useful for treating conditions caused by viral infections, including COVID-19.

Abstract: A composition and a method are provided for improving number and/or function of muscle satellite cells, and/or treating or preventing muscle atrophy in a subject in need thereof. Such a composition comprising a homogenous polysaccharide or a derivative thereof, or a pharmaceutically acceptable ester or salt thereof, or a pharmaceutically acceptable solvate thereof, or any combination thereof, and a pharmaceutically acceptable excipient. The homogeneous polysaccharide consists essentially of arabinose, galactose, rhamnose, and galacturonic acid as monomer units. Such a method comprises administrating an effective amount of such a composition into a subject in need thereof.

Abstract: A method may include receiving input for a multiwell structure and subsurface target locations, where the multiwell structure includes slots; generating, based at least in part on the input, a position for the multiwell structure, slot-well assignments for the slots, and well trajectories, where each of the well trajectories extends from an assigned one of the slots to one or more of the subsurface target locations; and outputting a set of specifications for the position for the multiwell structure, the well trajectories, and an order for drilling the well trajectories.

Abstract: The present disclosure provides a data processing method and device, the method includes: acquiring exercise data of a user in a preset time period and a physical parameter preset by the user, wherein the exercise data comprises exercise data of a head, a hand and a leg of the user; and inputting the exercise data and the physical parameter into a pre-trained energy determination model for processing to obtain energy consumed by the user in the preset time period.

Abstract: An electronic device that includes a display and an eye tracker configured to collect eye tracking data regarding a gaze of one or more of a user's eyes across the display is disclosed herein. The electronic device includes processing circuitry that is operatively coupled to the display and configured to foveate one or more areas of the display according to the eye tracking data. If the eye tracking data input is lost, the processing circuitry is configured to recover from the loss of eye tracking data by changing one or more aspects of the foveated areas (e.g., size, resolution, etc.) until a threshold is satisfied. As time elapses since loss of eye tracking, the foveated areas move toward a center or a salient region of the display.

Abstract: According to embodiments of the disclosure, a method, apparatus, device, and storage medium for image processing are provided. In this method, an image sensing unit array of a camera is divided into a set of full processing units and at least one set of partial processing units based on a characteristic of a lens of the camera, and/or a current gazing point of a user of the camera. Within at least one stage of a plurality of stages of an imaging process using the camera, a processing load associated with at least some units of the partial processing units is reduced.

Abstract: Provided herein, inter alia, are compounds, pharmaceutical compositions and methods related to the treatment of viral infections caused by coronavirus or enterovirus. Provided herein are compounds of Formula (I), (II) and (III) and methods of using the compounds for therapy. These compounds are peptidomimetics that inhibit protease 3CL of a coronavirus, and are useful for treating conditions caused by viral infections, including COVID-19.

Abstract: A multi-layer low-pass filter is used to filter a first frame of video data representing at least a portion of an environment of an individual. A first layer of the filter has a first filtering resolution setting for a first subset of the first frame, while a second layer of the filter has a second filtering resolution setting for a second subset. The first subset includes a data element positioned along a direction of a gaze of the individual, and the second subset of the frame surrounds the first subset. A result of the filtering is compressed and transmitted via a network to a video processing engine configured to generate a modified visual representation of the environment.

Abstract: A multi-layer low-pass filter is used to filter a first frame of video data representing at least a portion of an environment of an individual. A first layer of the filter has a first filtering resolution setting for a first subset of the first frame, while a second layer of the filter has a second filtering resolution setting for a second subset. The first subset includes a data element positioned along a direction of a gaze of the individual, and the second subset of the frame surrounds the first subset. A result of the filtering is compressed and transmitted via a network to a video processing engine configured to generate a modified visual representation of the environment.

Abstract: This disclosure relates, inter alia to: modified interleukin 2 (IL-2) polypeptides; RNA polynucleotides, DNA polynucleotides, non-viral vectors, and viral vectors encoding such modified IL-2 polypeptides; methods of making such modified IL-2 polypeptides and RNA polynucleotides, DNA polynucleotides, non-viral vectors, and viral vectors encoding same; and methods of using such modified IL-2 polypeptides and RNA polynucleotides, DNA polynucleotides, non-viral vectors, and viral vectors encoding same.

Abstract: A multi-layer low-pass filter is used to filter a first frame of video data representing at least a portion of an environment of an individual. A first layer of the filter has a first filtering resolution setting for a first subset of the first frame, while a second layer of the filter has a second filtering resolution setting for a second subset. The first subset includes a data element positioned along a direction of a gaze of the individual, and the second subset of the frame surrounds the first subset. A result of the filtering is compressed and transmitted via a network to a video processing engine configured to generate a modified visual representation of the environment.

Abstract: An electronic device that includes a display and an eye tracker configured to collect eye tracking data regarding a gaze of one or more of a user's eyes across the display is disclosed herein. The electronic device includes processing circuitry that is operatively coupled to the display and configured to foveate one or more areas of the display according to the eye tracking data. If the eye tracking data input is lost, the processing circuitry is configured to recover from the loss of eye tracking data by changing one or more aspects of the foveated areas (e.g., size, resolution, etc.) until a threshold is satisfied. As time elapses since loss of eye tracking, the foveated areas move toward a center or a salient region of the display.

Abstract: An electronic device that includes a display and an eye tracker configured to collect eye tracking data regarding a gaze of one or more of a user's eyes across the display is disclosed herein. The electronic device includes processing circuitry that is operatively coupled to the display and configured to foveate one or more areas of the display according to the eye tracking data. If the eye tracking data input is lost, the processing circuitry is configured to recover from the loss of eye tracking data by changing one or more aspects of the foveated areas (e.g., size, resolution, etc.) until a threshold is satisfied. As time elapses since loss of eye tracking, the foveated areas move toward a center or a salient region of the display.

Abstract: Provided herein, inter alia, are compounds, pharmaceutical compositions and methods related to the treatment of viral infections caused by coronavirus or enterovirus. Provided herein are compounds of Formula (I), (II) and (III) and methods of using the compounds for therapy. These compounds are peptidomimetics that inhibit protease 3CL of a coronavirus, and are useful for treating conditions caused by viral infections, including COVID-19.

Abstract: A multi-layer low-pass filter is used to filter a first frame of video data representing at least a portion of an environment of an individual. A first layer of the filter has a first filtering resolution setting for a first subset of the first frame, while a second layer of the filter has a second filtering resolution setting for a second subset. The first subset includes a data element positioned along a direction of a gaze of the individual, and the second subset of the frame surrounds the first subset. A result of the filtering is compressed and transmitted via a network to a video processing engine configured to generate a modified visual representation of the environment.

Abstract: Provided herein, inter alia, are compounds, pharmaceutical compositions and methods related to the treatment of viral infections caused by coronavirus or enterovirus. Provided herein are compounds of Formula (I), (II) and (III) and methods of using the compounds for therapy. These compounds are peptidomimetics that inhibit protease 3CL of a coronavirus, and are useful for treating conditions caused by viral infections, including COVID-19.

Abstract: Provided herein, inter alia, are compounds, pharmaceutical compositions and methods related to the treatment of viral infections caused by coronavirus or enterovirus. Provided herein are compounds of Formula (I), (II) and (III) and methods of using the compounds for therapy. These compounds are peptidomimetics that inhibit protease 3CL of a coronavirus, and are useful for treating conditions caused by viral infections, including COVID-19.

Abstract: This disclosure relates to modified interleukin 2 (IL-2) polypeptides, polynucleotides, e.g., DNA, RNA or viral vector, that encode the modified IL-2 polypeptides and are configured to express said modified IL-2 polypeptides in vitro and/or in vivo, conjugates comprising the modified IL-2 polypeptides, and uses thereof.

Abstract: A multi-layer low-pass filter is used to filter a first frame of video data representing at least a portion of an environment of an individual. A first layer of the filter has a first filtering resolution setting for a first subset of the first frame, while a second layer of the filter has a second filtering resolution setting for a second subset. The first subset includes a data element positioned along a direction of a gaze of the individual, and the second subset of the frame surrounds the first subset. A result of the filtering is compressed and transmitted via a network to a video processing engine configured to generate a modified visual representation of the environment.

Abstract: An electronic device may include a display panel with pixels that present an image based on image data and an application processor that generates the image data. The electronic device may include a display pipeline coupled to the electronic display and the application processor. The display pipeline may receive first image data from the application processor corresponding to a first color space used by the application processor. The display pipeline may apply a color mapping relationship to the first image data to generate second image data. The color mapping relationship may define a transform to apply to the first image data to generate the second image data corresponding to a second color space used by the electronic display. The display pipeline may transmit the second image data to a display driver that operates the electronic display to emit light according to the second image data.